{"organizations": [], "uuid": "19fbbd2b8598c1026e5c8e18b0e83028cbd15a3a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-prokaryotics-announces-licensing-a/brief-prokaryotics-announces-licensing-agreement-with-merck-for-novel-investigational-antibiotic-candidates-idUSFWN1PK1A4", "country": "US", "domain_rank": 408, "title": "BRIEF-Prokaryotics Announces Licensing Agreement With Merck For Novel Investigational Antibiotic Candidates", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-25T15:46:00.000+02:00", "replies_count": 0, "uuid": "19fbbd2b8598c1026e5c8e18b0e83028cbd15a3a"}, "author": "", "url": "https://www.reuters.com/article/brief-prokaryotics-announces-licensing-a/brief-prokaryotics-announces-licensing-agreement-with-merck-for-novel-investigational-antibiotic-candidates-idUSFWN1PK1A4", "ord_in_thread": 0, "title": "BRIEF-Prokaryotics Announces Licensing Agreement With Merck For Novel Investigational Antibiotic Candidates", "locations": [], "entities": {"persons": [{"name": "merck for nove", "sentiment": "negative"}, {"name": "merck", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters) - merck & co inc", "sentiment": "none"}, {"name": "investigational antibiotic candidates reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 46 PM / Updated 12 minutes ago BRIEF-Prokaryotics Announces Licensing Agreement With Merck For Novel Investigational Antibiotic Candidates Reuters Staff \nJan 25 (Reuters) - Merck & Co Inc: \n* PROKARYOTICS ANNOUNCES LICENSING AGREEMENT WITH MERCK FOR NOVEL INVESTIGATIONAL ANTIBIOTIC CANDIDATES \n* PROKARYOTICS - ANNOUNCES LICENSING AGREEMENT WITH MERCK FOR NOVEL INVESTIGATIONAL ANTIBIOTIC CANDIDATES \n* PROKARYOTICS - CO GAINS WORLDWIDE RIGHTS TO DEVELOP EARLY PRE-CLINICAL PROGRAMS FOR GRAM-NEGATIVE, GRAM-POSITIVE BACTERIAL CELL ENVELOPE ENZYMES \n* PROKARYOTICS - SPECIFIC TERMS OF AGREEMENT WERE NOT DISCLOSED Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-25T15:46:00.000+02:00", "crawled": "2018-01-25T16:04:40.009+02:00", "highlightTitle": ""}